These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 35409062)

  • 21. Network neighborhood operates as a drug repositioning method for cancer treatment.
    Cüvitoğlu A; Isik Z
    PeerJ; 2023; 11():e15624. PubMed ID: 37456868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computational Drug Repositioning with Random Walk on a Heterogeneous Network.
    Luo H; Wang J; Li M; Luo J; Ni P; Zhao K; Wu FX; Pan Y
    IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(6):1890-1900. PubMed ID: 29994051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting Potential Drugs for Breast Cancer based on miRNA and Tissue Specificity.
    Yu L; Zhao J; Gao L
    Int J Biol Sci; 2018; 14(8):971-982. PubMed ID: 29989066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computational drug repurposing by exploiting large-scale gene expression data: Strategy, methods and applications.
    He H; Duo H; Hao Y; Zhang X; Zhou X; Zeng Y; Li Y; Li B
    Comput Biol Med; 2023 Mar; 155():106671. PubMed ID: 36805225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
    Wang Y; Yella J; Jegga AG
    Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Analytical Review of Computational Drug Repurposing.
    Sadeghi SS; Keyvanpour MR
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(2):472-488. PubMed ID: 31403439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Turning liabilities into opportunities: Off-target based drug repurposing in cancer.
    Palve V; Liao Y; Remsing Rix LL; Rix U
    Semin Cancer Biol; 2021 Jan; 68():209-229. PubMed ID: 32044472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The module triad: a novel network biology approach to utilize patients' multi-omics data for target discovery in ulcerative colitis.
    Voitalov I; Zhang L; Kilpatrick C; Withers JB; Saleh A; Akmaev VR; Ghiassian SD
    Sci Rep; 2022 Dec; 12(1):21685. PubMed ID: 36522454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new computational drug repurposing method using established disease-drug pair knowledge.
    Saberian N; Peyvandipour A; Donato M; Ansari S; Draghici S
    Bioinformatics; 2019 Oct; 35(19):3672-3678. PubMed ID: 30840053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug repositioning in SLE: crowd-sourcing, literature-mining and Big Data analysis.
    Grammer AC; Ryals MM; Heuer SE; Robl RD; Madamanchi S; Davis LS; Lauwerys B; Catalina MD; Lipsky PE
    Lupus; 2016 Sep; 25(10):1150-70. PubMed ID: 27497259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
    Turanli B; Gulfidan G; Arga KY
    OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Considerations and challenges for sex-aware drug repurposing.
    Fisher JL; Jones EF; Flanary VL; Williams AS; Ramsey EJ; Lasseigne BN
    Biol Sex Differ; 2022 Mar; 13(1):13. PubMed ID: 35337371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generating new drug repurposing hypotheses using disease-specific hypergraphs.
    Jain A; Charpignon ML; Chen IY; Philippakis A; Alaa A
    Pac Symp Biocomput; 2024; 29():261-275. PubMed ID: 38160285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Thiol-polyamine Metabolism of Trypanosoma cruzi: Molecular Targets and Drug Repurposing Strategies.
    Talevi A; Carrillo C; Comini M
    Curr Med Chem; 2019; 26(36):6614-6635. PubMed ID: 30259812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive network medicine-based drug repositioning via integration of therapeutic efficacy and side effects.
    Paci P; Fiscon G; Conte F; Wang RS; Handy DE; Farina L; Loscalzo J
    NPJ Syst Biol Appl; 2022 Apr; 8(1):12. PubMed ID: 35443763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug repurposing: a promising tool to accelerate the drug discovery process.
    Parvathaneni V; Kulkarni NS; Muth A; Gupta V
    Drug Discov Today; 2019 Oct; 24(10):2076-2085. PubMed ID: 31238113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery.
    Roy S; Dhaneshwar S; Bhasin B
    Curr Drug Res Rev; 2021; 13(2):101-119. PubMed ID: 33573567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks.
    Liu H; Song Y; Guan J; Luo L; Zhuang Z
    BMC Bioinformatics; 2016 Dec; 17(Suppl 17):539. PubMed ID: 28155639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using a novel computational drug-repositioning approach (DrugPredict) to rapidly identify potent drug candidates for cancer treatment.
    Nagaraj AB; Wang QQ; Joseph P; Zheng C; Chen Y; Kovalenko O; Singh S; Armstrong A; Resnick K; Zanotti K; Waggoner S; Xu R; DiFeo A
    Oncogene; 2018 Jan; 37(3):403-414. PubMed ID: 28967908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.